Showing results (181-190 of 429) with videos related to
Sort By:
Pageof 43
Progress in Clinical and Biological Research|January 1, 1987
Graft-vs-leukemia following bone marrow transplantation: a model of immunotherapy in manA Butturini, M M Bortin, R C Seeger, et al.Cancer Research|July 1, 1997
p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32betaE J Fuchs, K A McKenna, A BediScience (New York, N.Y.)|March 22, 1996
Neonatal tolerance revisited: turning on newborn T cells with dendritic cellsJ P Ridge, E J Fuchs, P MatzingerLancet (London, England)|February 21, 1987
Which treatment for childhood acute lymphoblastic leukaemia in second remission?A Butturini, G K Rivera, M M Bortin, et al.Bone Marrow Transplantation|January 1, 1990
Fulminant hepatic failure following bone marrow transplantation for hepatitis-associated aplastic anemiaJ Van Dam, F A Farraye, R P Gale, et al.American Journal of Clinical Pathology|September 1, 1980
Acute lymphoblastic leukemia with giant intracytoplasmic inclusionsE T Yanagihara, F Naeim, R P Gale, et al.American Journal of Clinical Pathology|April 1, 1981
Fatal veno-occlusive disease of the liver following high-dose 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and autologous bone marrow transplantationR E McIntyre, J G Magidson, G E Austin, et al.Eye (London, England)|August 28, 2007
Benchmark standards for refractive outcomes after NHS cataract surgeryR P Gale, M Saldana, R L Johnston, et al.European Journal of Cancer & Clinical Oncology|January 1, 1988
Prophylaxis of infection in bone marrow transplantsD J Winston, W G Ho, R P Gale, et al.Archives of Internal Medicine|September 1, 1983
The role of immunotherapy in acute myelogenous leukemiaK A Foon, R V Smalley, C W Riggs, et al.Pageof 43